Lh. Kornman et al., MATERNAL URINARY BETA-CORE HCG IN CHROMOSOMALLY ABNORMAL PREGNANCIES IN THE FIRST TRIMESTER, Prenatal diagnosis, 17(2), 1997, pp. 135-139
We evaluated urinary beta-core human chorionic gonadotropin (beta-core
hCG) in the detection of fetal Down's syndrome (DS) in the first trim
ester of pregnancy. Urine was collected prior to performing chorionic
villous sampling (CVS) between 10 and 12 completed weeks from the last
menstrual period. In the 9 months of the study, there were 15 chromos
omal abnormalities detected by CVS: five trisomy 21, four monosomy X,
two trisomy 18, and four cases of confined placental mosaicism (CPM).
In these 15 aneuploid pregnancies, the levels of urinary beta-core hCG
were expressed as multiples of the median (MOM) of the ratio of beta-
core hCG/creatinine for gestational age. The MOMs of this ratio in eac
h of the five DS pregnancies were 0.2, 0.5, 1.3, 1.4, and 1.7. No diff
erence was found between fetuses with DS or any of the other chromosom
al abnormalities tested and normal fetuses. Contrary to optimistic rep
orts of urinary beta-core hCG in the second-trimester detection of fet
al DS, our data suggest that this is not a useful screening test for D
S in the first trimester of pregnancy. (C) 1997 by John Wiley & Sons,
Ltd.